Bayer Cropscience operates in pesticides and agrochemicals, with market cap ₹18,165 Cr. Shows strong ROE at 23.7%, but recent quarters reveal significant earnings volatility and declining revenue.
Generated analysis · source review pending
Generated analysis · source review pending
2,528 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | 42.6% | 43.7% | 45.2% | 42.9% | — | 40.5% |
| EBITDA margin % | 13.9% | 19.5% | 19.1% | 17.1% | 18% | 19% | 12.6% | 15.4% |
| EBIT margin % | 12.6% | 17.6% | 17.3% | 15.8% | 16.4% | 17.2% | 11% | 13.7% |
| PAT margin % | 8.9% | 12% | 11.6% | 13.6% | 14.8% | 14.5% | 10.4% | 12.1% |
| Working capital | ||||||||
| Receivable days | 95 | 79 | 65 | 77 | 69 | 69 | 64 | 72 |
| Inventory days | 183 | 132 | 198 | 207 | 234 | 194 | 180 | 231 |
| Payable days | 102 | 1 | 124 | 112 | 113 | 76 | 2 | 3 |
| NWC days | 176 | 210 | 138 | 172 | 190 | 187 | 242 | 300 |
| Leverage | ||||||||
| Current ratio | 2.34 | 2.65 | 2.26 | 2.15 | 2.19 | 2.44 | 2.01 | 1.92 |
| Debt to EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Interest coverage | 38 | 46.8 | 63.7 | 62.1 | 40.7 | 49 | 42.6 | 44.2 |
| Asset turnover | 0.76 | 0.87 | 1.01 | 1.09 | 1.1 | 1.11 | 1.04 | 1 |
| Return ratios | ||||||||
| Return on assets % | 6.7% | 10.4% | 11.6% | 14.8% | 16.2% | 16.1% | 10.8% | 12.1% |
| Return on capital employed % | 17.8% | 25.3% | 29.9% | 29.9% | 32.5% | 32.6% | 24.1% | 28.4% |
| Return on equity % | 10.7% | 15.5% | 19.3% | 25.6% | 28% | 26% | 19.9% | 23.2% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | |
| 3.3% | 3.54% | 3.62% | 3.63% | 3.3% | 3.42% | 3.49% | 3.64% | 3.79% | 3.84% | 3.89% | 3.97% | |
| 13.23% | 12.7% | 12.8% | 12.47% | 12.08% | 11.7% | 11.55% | 11.38% | 11.21% | 11.46% | 11.89% | 11.64% | |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 12.04% | 12.33% | 12.15% | 12.47% | 13.19% | 13.45% | 13.53% | 13.55% | 13.57% | 13.27% | 12.79% | 12.96% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 58,109 | 58,571 | 55,795 | 58,884 |
Documents link to external sources (exchange filings, company investor pages).
Promoter holding up 0 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 8 Jul 2026 | BAYER CROPSCIENCE AKTIENGESELLSCHAFT | Block | NSE | Sell | 53,54,030 | ₹4,122.30 | ₹2,207.09 Cr |
| 8 Jul 2026 | BAYER AG | Block | NSE | Buy | 53,54,030 | ₹4,122.30 | ₹2,207.09 Cr |
| 8 Jul 2026 | BAYER CROPSCIENCE AKTIENGESELLSCHAFT | Bulk | NSE | Sell | 53,54,030 | ₹4,122.30 | ₹2,207.09 Cr |
| 8 Jul 2026 | BAYER AG | Bulk | NSE | Buy | 53,54,030 | ₹4,122.30 | ₹2,207.09 Cr |
| 25 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | BSE | Sell | 33,939 | ₹4,696.70 | ₹15.94 Cr |
| 25 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | Block | BSE | Buy | 33,939 | ₹4,696.70 | ₹15.94 Cr |
| 25 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | Block | BSE | Buy | 4,645 | ₹4,696.70 | ₹2.18 Cr |
| 25 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | Block | BSE | Sell | 4,645 | ₹4,696.70 | ₹2.18 Cr |
| 17 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | Block | BSE | Buy | 33,905 | ₹4,649.55 | ₹15.76 Cr |
| 17 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | BSE | Sell | 33,905 | ₹4,649.55 | ₹15.76 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Upl LimitedUPLUPL | ₹43,628 Cr | ₹65,674 Cr | ₹52,804 Cr | ₹9,326 Cr | 17.9% | ₹2,020 Cr | 4.3% | 11.2% | 6% | 135 |
| Sumitomo Chemical India LimitedSUMICHEMSUMICHEM | ₹20,842 Cr | ₹20,844 Cr | ₹3,245 Cr | ₹685 Cr | 20.7% | ₹579 Cr | 16.8% | 23.1% | 17.3% | 155 |
| Bayer Cropscience LimitedBAYERCROPBAYERCROP | ₹15,958 Cr | — | ₹5,472 Cr | ₹688 Cr | 15.4% | ₹568 Cr | 12.1% | 28.4% | 23.7% | 300 |
| Sharda Cropchem LimitedSHARDACROPSHARDACROP | ₹6,397 Cr | ₹6,397 Cr | ₹5,357 Cr | ₹1,047 Cr | 20.4% | ₹626 Cr | 12.9% | 28% | 24.2% | 125 |
| Dhanuka Agritech LimitedDHANUKADHANUKA | ₹4,217 Cr | ₹4,259 Cr | ₹2,035 Cr | ₹417 Cr | 20.5% | ₹297 Cr | 14.6% | 28.9% | 22.3% | 160 |
| Rallis India LimitedRALLISRALLIS | ₹3,884 Cr | ₹3,942 Cr | ₹2,604 Cr | ₹274 Cr | 10.5% | ₹164 Cr | 6.3% | 13.2% | 10% | 104 |
| Bhagiradha Chemicals & Industries LimitedBHAGCHEMBHAGCHEM | ₹3,063 Cr | ₹3,294 Cr | ₹607 Cr | ₹79 Cr | 10.7% | ₹28 Cr | 3.4% | 4.8% | 2.6% | 148 |
| Nacl Industries LimitedNACLINDNACLIND | ₹3,054 Cr | ₹3,355 Cr | ₹1,519 Cr | ₹106 Cr | 6.5% | ₹12 Cr | 0.3% | 11.8% | 0.8% | 105 |
| Gsp Crop Science LimitedGSPCROPGSPCROP | ₹2,113 Cr | ₹2,373 Cr | ₹1,517 Cr | ₹185 Cr | 12.2% | ₹-3 Cr | 6.2% | 20.7% | -0.4% | 121 |
| Bharat Rasayan LimitedBHARATRASBHARATRAS | ₹1,658 Cr | ₹1,659 Cr | ₹1,203 Cr | ₹177 Cr | 16% | ₹140 Cr | 11.7% | 17.5% | 12.1% | 219 |
| Insecticides (India) LimitedINSECTICIDINSECTICID | ₹1,655 Cr | ₹1,799 Cr | ₹2,060 Cr | ₹210 Cr | 10.6% | ₹125 Cr | 6.5% | 17.1% | 12.1% | 168 |
| Astec Lifesciences LimitedASTECASTEC | ₹1,580 Cr | ₹2,029 Cr | ₹441 Cr | ₹6 Cr | -1% | ₹-67 Cr | -18.1% | -9.3% | -25.9% | 263 |
37 schemes · 10 fund houses
| Shares | ||||||
|---|---|---|---|---|---|---|
| Small Cap Fund | DSP Mutual Fund | 5.78 L | 229.44 | 1.06% | 1.287% | -0 |
| SMALL CAP FUND | Nippon India Mutual Fund | 5.66 L | 224.81 | 0.27% | 1.261% | -0 |
| Multi Asset Allocation Fund | DSP Mutual Fund | 1.96 L | 77.75 | 0.71% | 0.436% | -0 |
| INDIA PHARMA & HEALTHCARE FUND | Tata Mutual Fund | 1.19 L | 47.18 | 3.01% | 0.265% | -0 |
| Multi Cap Fund (Ex DSP Multi Cap Fund)NEW | DSP Mutual Fund | 88,177 | 35.01 | 1.16% | 0.196% | — |
| BUSINESS CYCLE FUND | Tata Mutual Fund | 67,929 | 26.97 | 1.04% | 0.151% | -0 |
| FLEXI CAP FUND | Tata Mutual Fund | 38,612 | 15.33 | 0.42% | 0.086% | -0 |
| Multi Cap FUND | Bank of India Mutual Fund | 28,795 | 11.43 | 0.86% | 0.064% | -0 |
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation Of Postal Ballot And Tentative Calendar Of Events
Announcement Under Regulation 30 Regarding ESG Rating By Crisil ESG Ratings And Analytics Limited
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
| Date | Category | Subject | Filing |
|---|---|---|---|
| 18 Sept 2026, 4:53 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window | |
| 18 Sept 2026, 11:38 am | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 12 Sept 2026, 12:41 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 11 Sept 2026, 3:46 pm | AGM/EGM Postal Ballot | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| 9 Sept 2026, 11:18 am | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 8 Sept 2026, 12:09 pm | AGM/EGM Postal Ballot | Intimation Of Postal Ballot And Tentative Calendar Of Events |
| 1 Sept 2026, 5:14 pm | Company Update General | Announcement Under Regulation 30 Regarding ESG Rating By Crisil ESG Ratings And Analytics Limited |
| 26 Aug 2026, 4:07 pm | Company Update Analyst / Investor Meet | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,644 | 2,886 | 2,749 | 2,686 | 3,323 | 4,261 | 4,734 | 5,140 | 5,103 | 5,472 | 5,675 | |
| COGS | -2,488 | -1,804 | -1,601 | -1,486 | -1,769 | 2,446 | 2,664 | 2,816 | 2,912 | -3,399 | 3,378 |
| Gross profit | — | — | — | — | — | 1,815 | 2,070 | 2,324 | 2,192 | — | 2,298 |
| 5,812 | 4,347 | 3,948 | 3,799 | 4,444 | 1,004 | 1,259 | 1,400 | 1,222 | 8,183 | 1,424 | |
| Operating profit (EBITDA) | 320 | 343 | 401 | 373 | 649 | 812 | 811 | 924 | 970 | 688 | 874 |
| OPM % | 8.8% | 11.9% | 14.6% | 13.9% | 19.5% | 19.1% | 17.1% | 18% | 19% | 12.6% | 15.4% |
| Depreciation | 25 | — | — | 34 | 62 | 74 | 65 | 80 | 90 | 85 | 94 |
| Interest | 7 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 | 20 |
| 76 | 70 | 39 | 37 | -75 | 69 | 113 | 168 | 81 | 121 | 95 | |
| Profit before tax | 463 | 448 | 404 | 366 | 497 | 795 | 847 | 990 | 941 | 707 | 855 |
| Tax | 162 | 157 | 104 | 129 | 99 | 301 | 202 | 232 | 201 | 139 | 166 |
| Tax % | 35% | 35% | 25.7% | 35.1% | 19.9% | 37.9% | 23.8% | 23.4% | 21.3% | 19.7% | 19.4% |
| 301 | 291 | 300 | 238 | 399 | 493 | 645 | 758 | 741 | 568 | 689 | |
| PAT margin % | 8.3% | 10.1% | 10.9% | 8.9% | 12% | 11.6% | 13.6% | 14.8% | 14.5% | 10.4% | 12.1% |
| EPS (₹) | 82.5 | 82.3 | 85 | 69.2 | 92.7 | 109.7 | 143.6 | 168.7 | 164.8 | 94.5 | — |
| EPS adjusted (₹) | 82.2 | 82.2 | 87.5 | 69.3 | 88.8 | 109.8 | 143.7 | 168.9 | 164.9 | 126.5 | 153.5 |
| 20.6% | 20.7% | 21.2% | 26% | 27% | 218.7% | 17.4% | 77.1% | 85% | 132.3% | — | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 37 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 2,074 | 1,804 | 1,744 | 2,195 | 2,528 | 2,505 | 2,479 | 2,667 | 2,805 | 2,806 | 2,921 |
| Minority interest | — | — | — | 11 | — | — | — | — | — | — | — |
| — | — | — | 2 | 2 | 0 | 0 | 0 | 0 | — | — | |
| 639 | 597 | 757 | 1,308 | 1,262 | 1,689 | 1,829 | 1,967 | 1,748 | 2,396 | 2,734 | |
| Total equity & liabilities | 2,750 | 2,437 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
| 294 | 290 | 304 | 409 | 438 | 395 | 441 | 437 | 389 | 445 | 434 | |
| CWIP | 0 | 7 | 1 | 7 | 4 | 8 | 13 | 3 | 6 | 1 | 5 |
| Investments | 25 | 36 | 351 | 41 | 41 | 82 | 65 | 67 | 79 | 35 | 57 |
| 2,430 | 2,103 | 1,879 | 3,092 | 3,353 | 3,755 | 3,834 | 4,172 | 4,122 | 4,765 | 5,203 | |
| Total assets | 2,750 | 2,437 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 207 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 | 1,079 | |
| 16 | -8 | 38 | -415 | -29 | 7 | 64 | 83 | 0 | 86 | 73 | |
| -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 | -624 | |
| Net cash flow | -367 | 76 | -421 | -140 | 489 | 138 | -424 | 79 | 296 | -272 | 527 |
| Free cash flow | — | — | — | 373 | 625 | 645 | 182 | 565 | 919 | — | — |
| CFO / Operating profit % | 64.5% | 45.9% | 30.2% | 116% | 102.7% | 84.6% | 26.6% | 65.9% | 98.2% | 38.1% | 123.4% |